EE9900263A - Tetrahüdropüridiinderivaadi mikropartikulaarne vorm - Google Patents

Tetrahüdropüridiinderivaadi mikropartikulaarne vorm

Info

Publication number
EE9900263A
EE9900263A EEP199900263A EE9900263A EE9900263A EE 9900263 A EE9900263 A EE 9900263A EE P199900263 A EEP199900263 A EE P199900263A EE 9900263 A EE9900263 A EE 9900263A EE 9900263 A EE9900263 A EE 9900263A
Authority
EE
Estonia
Prior art keywords
microparticulate form
tetrahydropyridine derivative
tetrahydropyridine
derivative
microparticulate
Prior art date
Application number
EEP199900263A
Other languages
English (en)
Other versions
EE04112B1 (et
Inventor
Caron Antoine
Chambon Jean-Pierre
Monnier Olivier
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of EE9900263A publication Critical patent/EE9900263A/et
Publication of EE04112B1 publication Critical patent/EE04112B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
EEP199900263A 1996-12-23 1997-12-23 Tetrahüdropüridiinderivaadi mikropartikulaarne vorm EE04112B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine
PCT/FR1997/002394 WO1998028272A1 (fr) 1996-12-23 1997-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (2)

Publication Number Publication Date
EE9900263A true EE9900263A (et) 2000-02-15
EE04112B1 EE04112B1 (et) 2003-08-15

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900263A EE04112B1 (et) 1996-12-23 1997-12-23 Tetrahüdropüridiinderivaadi mikropartikulaarne vorm

Country Status (38)

Country Link
US (4) US20020028247A1 (et)
EP (1) EP0950051B1 (et)
JP (2) JP4422214B2 (et)
KR (1) KR100455797B1 (et)
CN (1) CN1088698C (et)
AR (1) AR009673A1 (et)
AT (1) ATE250032T1 (et)
AU (1) AU730302B2 (et)
BR (1) BR9714177A (et)
CA (1) CA2275593C (et)
CO (1) CO4920213A1 (et)
CZ (1) CZ294272B6 (et)
DE (1) DE69724999T2 (et)
DK (1) DK0950051T3 (et)
DZ (1) DZ2386A1 (et)
EE (1) EE04112B1 (et)
EG (1) EG24749A (et)
ES (1) ES2207758T3 (et)
FR (1) FR2757510B1 (et)
HK (1) HK1024000A1 (et)
HU (1) HU224348B1 (et)
IL (1) IL129937A (et)
IN (1) IN186977B (et)
IS (1) IS2064B (et)
MY (1) MY126298A (et)
NO (1) NO311569B1 (et)
NZ (1) NZ336129A (et)
PL (1) PL190098B1 (et)
PT (1) PT950051E (et)
RU (1) RU2193031C2 (et)
SI (1) SI0950051T1 (et)
SK (1) SK283917B6 (et)
TR (1) TR199901362T2 (et)
TW (1) TW534820B (et)
UA (1) UA66776C2 (et)
WO (1) WO1998028272A1 (et)
YU (1) YU49427B (et)
ZA (1) ZA9711579B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4570357B2 (ja) * 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
CA2126685C (en) * 1992-10-26 2002-07-23 Bruno Gander Process for the production of microcapsules
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
SI0950051T1 (en) 2004-02-29
JP2001507013A (ja) 2001-05-29
CN1088698C (zh) 2002-08-07
DE69724999T2 (de) 2004-07-22
IL129937A0 (en) 2000-02-29
CO4920213A1 (es) 2000-05-29
HU224348B1 (hu) 2005-08-29
HK1024000A1 (en) 2000-09-29
YU28899A (sh) 2000-03-21
CZ229199A3 (cs) 1999-09-15
AR009673A1 (es) 2000-04-26
DK0950051T3 (da) 2004-01-26
NO311569B1 (no) 2001-12-10
RU2193031C2 (ru) 2002-11-20
JP2009280581A (ja) 2009-12-03
TR199901362T2 (xx) 1999-09-21
US20020192292A1 (en) 2002-12-19
CN1241179A (zh) 2000-01-12
EE04112B1 (et) 2003-08-15
ES2207758T3 (es) 2004-06-01
NO993077D0 (no) 1999-06-22
FR2757510B1 (fr) 2000-01-07
HUP0001181A2 (hu) 2000-11-28
DZ2386A1 (fr) 2002-12-28
EP0950051B1 (fr) 2003-09-17
ATE250032T1 (de) 2003-10-15
KR20000069503A (ko) 2000-11-25
CA2275593C (en) 2005-12-20
IN186977B (et) 2001-12-22
BR9714177A (pt) 2000-02-29
CZ294272B6 (cs) 2004-11-10
US20020028247A1 (en) 2002-03-07
JP4422214B2 (ja) 2010-02-24
PL190098B1 (pl) 2005-10-31
TW534820B (en) 2003-06-01
DE69724999D1 (de) 2003-10-23
YU49427B (sh) 2006-01-16
KR100455797B1 (ko) 2004-11-06
SK82999A3 (en) 1999-12-10
PL334276A1 (en) 2000-02-14
ZA9711579B (en) 1998-06-25
PT950051E (pt) 2004-02-27
UA66776C2 (uk) 2004-06-15
EP0950051A1 (fr) 1999-10-20
US20100021541A1 (en) 2010-01-28
IL129937A (en) 2002-09-12
AU730302B2 (en) 2001-03-01
WO1998028272A1 (fr) 1998-07-02
US20080255365A1 (en) 2008-10-16
SK283917B6 (sk) 2004-05-04
CA2275593A1 (en) 1998-07-02
FR2757510A1 (fr) 1998-06-26
IS5077A (is) 1999-06-10
AU5668598A (en) 1998-07-17
IS2064B (is) 2005-11-15
NO993077L (no) 1999-06-22
HUP0001181A3 (en) 2003-03-28
MY126298A (en) 2006-09-29
NZ336129A (en) 2000-11-24
EG24749A (en) 2010-07-20

Similar Documents

Publication Publication Date Title
DE69631390D1 (de) Substituierte Benzylaminpiperidin-Verbindungen
DE69815099D1 (de) Kosmetische zusammensetzungen
DE60033021D1 (de) Strukturierte kosmetische zusammensetzungen
PT839039E (pt) Composicoes de libertacao controlada de paroxetina
ID24481A (id) Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin
BR9605309A (pt) Composições de derivados piperazina
ATE278695T1 (de) Piperidinderivate
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69707782D1 (de) 4-Hydroxypiperidinderivate
DK0868183T3 (da) Injicerbare quinolonformuleringer
ID18352A (id) Komposisi-komposisi farmasi
DE69610553T2 (de) Deodorant zusammensetzungen
BR9708236A (pt) Composto pró-fragrância
DE69709833D1 (de) Wellenformentzerrer
DE60037014D1 (de) Kosmetische zusammensetzungen enthaltend polysaccharid-sterol-derivate
NO993460D0 (no) Paroxetine-preparater
ATE247105T1 (de) Antipsychotische 4-(1h-indolyl-1-yl)-1- substituierte piperidine derivate
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
PT941100E (pt) Composicoes farmaceuticas
EE04112B1 (et) Tetrahüdropüridiinderivaadi mikropartikulaarne vorm
ATE205830T1 (de) 4-hydroxypiperidinderivate
NO992302L (no) Piperidin-derivater
EE9900585A (et) 6-asauratsiili derivaadid IL-5 inhibiitoritena
NO20001778L (no) Substituerte piperidinderivater

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20111223